We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.
- Authors
Kass, Michael A; Heuer, Dale K; Higginbotham, Eve J; Johnson, Chris A; Keltner, John L; Miller, J Philip; Parrish, Richard K, 2nd; Wilson, M Roy; Gordon, Mae O
- Abstract
Primary open-angle glaucoma (POAG) is one of the leading causes of blindness in the United States and worldwide. Three to 6 million people in the United States are at increased risk for developing POAG because of elevated intraocular pressure (IOP), or ocular hypertension. There is no consensus on the efficacy of medical treatment in delaying or preventing the onset of POAG in individuals with elevated IOP. Therefore, we designed a randomized clinical trial, the Ocular Hypertension Treatment Study.
- Publication
Archives of ophthalmology (Chicago, Ill. : 1960), 2002, Vol 120, Issue 6, p701
- ISSN
0003-9950
- Publication type
Journal Article
- DOI
10.1001/archopht.120.6.701